Globus Medical (GMED) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Globus Medical Reports First Quarter 2017 Results
May 3, 2017 4:15 PM EDTAUDUBON, Pa., May 03, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced its financial results for the first quarter ended March 31, 2017.
Worldwide sales were $155.8 million, an increase of 11.9% as reported, or 12.1% in constant currencyFirst quarter net income was $28.7 million, or 18.4% of salesDiluted earnings per share (EPS) were $0.30Non-GAAP diluted EPS were $0.32Non-GAAP adjusted EBITDA was 37.1% of salesDavid Paul, Chairman and CEO said, Our worldwide sales for the first quarter were $155.8 million, an increase of 11.9%... More
